NYSE - Delayed Quote • USD
Becton, Dickinson and Company (BDX)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 6:54 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 12 | 12 |
| Avg. Estimate | 3.31 | 3.88 | 13.04 | 14.23 |
| Low Estimate | 3.27 | 3.77 | 12.98 | 14.05 |
| High Estimate | 3.37 | 3.93 | 13.09 | 14.42 |
| Year Ago EPS | 2.96 | 3.42 | 12.21 | 13.04 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 12 |
| Avg. Estimate | 5.07B | 5.39B | 20.22B | 21.38B |
| Low Estimate | 5.04B | 5.36B | 20.19B | 21.23B |
| High Estimate | 5.12B | 5.45B | 20.26B | 21.5B |
| Year Ago Sales | -- | 5.09B | 19.37B | 20.22B |
| Sales Growth (year/est) | -- | 6.00% | 4.40% | 5.70% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 2.91 | 3.43 | 2.4 | 2.97 |
| EPS Actual | 2.96 | 3.42 | 2.68 | 3.17 |
| Difference | 0.05 | -0.01 | 0.28 | 0.2 |
| Surprise % | 1.70% | -0.30% | 11.70% | 6.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 3.31 | 3.88 | 13.04 | 14.23 |
| 7 Days Ago | 3.31 | 3.88 | 13.04 | 14.25 |
| 30 Days Ago | 3.43 | 3.87 | 12.95 | 14.35 |
| 60 Days Ago | 3.43 | 3.87 | 12.94 | 14.34 |
| 90 Days Ago | 3.43 | 3.87 | 12.94 | 14.34 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 8 | 12 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| CURRENCY IN USD | BDX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 11.80% | -- | -- | 8.00% |
| Next Qtr. | 13.50% | -- | -- | 12.40% |
| Current Year | 6.80% | -- | -- | 5.60% |
| Next Year | 9.10% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 0.25% | -- | -- | 11.14% |
| Past 5 Years (per annum) | 1.37% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 5/6/2024 |
| Maintains | Barclays: Overweight to Overweight | 2/5/2024 |
| Maintains | Raymond James: Outperform to Outperform | 1/3/2024 |
| Maintains | Morgan Stanley: Overweight to Overweight | 12/4/2023 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/10/2023 |
| Maintains | Raymond James: Outperform to Outperform | 11/10/2023 |
Related Tickers
EMBC Embecta Corp.
14.45
+1.76%
BAX Baxter International Inc.
35.25
+0.23%
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
RMD ResMed Inc.
218.57
-0.64%
ISRG Intuitive Surgical, Inc.
398.82
+0.60%
ALC Alcon Inc.
88.83
-0.26%
HOLX Hologic, Inc.
75.02
+0.09%
TFX Teleflex Incorporated
217.64
-0.43%
COO The Cooper Companies, Inc.
97.31
-0.60%
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%